Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

Author's Avatar
Feb 27, 2021
Article's Main Image

Vote based on totality of scientific evidence provided by the Company including safety and efficacy data

PR Newswire